Yota Shimoda1,2, Hirohito Fujikawa3, Keisuke Komori1, Hayato Watanabe1, Kazuki Kano1, Takanobu Yamada1, Manabu Shiozawa1, Soichiro Morinaga1, Kenji Katsumata2, Akihiko Tsuchida2, Takashi Ogata1, Takashi Oshima4. 1. Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 2-3-2 Nakao Asahi Yokohama, Kanagawa, 241-8515, Japan. 2. Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan. 3. Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 2-3-2 Nakao Asahi Yokohama, Kanagawa, 241-8515, Japan. hiro_ic_ocean_29@yahoo.co.jp. 4. Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 2-3-2 Nakao Asahi Yokohama, Kanagawa, 241-8515, Japan. oshima@kcch.jp.
Abstract
PURPOSE: To assess the utility of the Glasgow Prognostic Score (GPS) obtained before curative resection for predicting outcomes in patients with advanced gastric cancer (GC). METHODS: This study retrospectively analyzed the outcomes of 337 consecutive patients with GC who underwent curative surgery for locally advanced gastric cancer between January 2003 and June 2014. GPS was assessed within 4 days prior to surgery. RESULTS: The number of patients with GPS scores of 0, 1, and 2 was 302, 26, and 9, respectively. There was significantly more blood loss during surgery and more postoperative complications in the GPS 1/2 group than in the GPS 0 group. Patients in the GPS 1/2 group had significantly poorer overall survival than those in the GPS 0 group (p = 0.001). On multivariate analysis, GPS 1/2 was identified as an independent factor for poor survival (p = 0.019). CONCLUSION: GPS before curative resection might be a useful predictive factor for perioperative complications and survival in locally advanced GC.
PURPOSE: To assess the utility of the Glasgow Prognostic Score (GPS) obtained before curative resection for predicting outcomes in patients with advanced gastric cancer (GC). METHODS: This study retrospectively analyzed the outcomes of 337 consecutive patients with GC who underwent curative surgery for locally advanced gastric cancer between January 2003 and June 2014. GPS was assessed within 4 days prior to surgery. RESULTS: The number of patients with GPS scores of 0, 1, and 2 was 302, 26, and 9, respectively. There was significantly more blood loss during surgery and more postoperative complications in the GPS 1/2 group than in the GPS 0 group. Patients in the GPS 1/2 group had significantly poorer overall survival than those in the GPS 0 group (p = 0.001). On multivariate analysis, GPS 1/2 was identified as an independent factor for poor survival (p = 0.019). CONCLUSION: GPS before curative resection might be a useful predictive factor for perioperative complications and survival in locally advanced GC.